Associate Professor, Medicine, Perelman School of Medicine
Cardiology
Dr. Thomas P. Cappola, MD
|
|
Give Review
Doctor Thomas P. Cappola, MD works in the field of Cardiology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He over the years received 2 awards: "Elected Member" and "CMS Meaningful Use Stage 1 Certification". Thomas P. Cappola, MD is a published physician as well. He has 67 publications published. The latest was: Causal Assessment of Serum Urate Levels inCardiometabolic Diseases Through a Mendelian Randomization Study. Thomas Cappola accepts Medicare payments and is listed with Medicare.gov.
Publications
- Development and evaluation of multi-marker risk scores for clinical prognosis.
- Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
- Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure.
- Effect of renal function on prognosis in chronic Heart failure.
- RNA-Seq identifies novel myocardial gene expression signatures of Heart failure.
- The Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure with Preserved Ejection Fraction.
- The Diastolic Pulmonary Gradient Does Not Predict Survival in Patients With Pulmonary Hypertension Due to Left Heart Disease.
- GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment St...
- Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes.
- An Enhancer Polymorphism at the Cardiomyocyte Intercalated Disc Protein NOS1AP Locus Is a Major Regulator of the QT Interval.
- Biomarker predictors of cardiac hospitalization in chronic Heart failure: a recurrent event analysis.
- Genetic association study of QT interval highlights role for calcium signaling pathways in Myocardial repolarization.
- Utility of gene expression profiling score variability to predict clinical events in Heart transplant recipients.
- Strain improves risk prediction beyond ejection fraction in chronic systolic Heart failure.
- Supercomputing for the parallelization of whole genome analysis.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Gene Expression and Genetic Variation in Human Atria.
- Ventricular-arterial coupling, remodeling, and prognosis in chronic Heart failure.
- BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure.
- Allopurinol improves myocardial efficiency in patients with idiopathic dilated Cardiomyopathy.
- Clinical considerations of heritable factors in common Heart failure.
- Differential Expression of PDE5 in Failing and Nonfailing Human Myocardium.
- Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated Heart failure.
- Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.
- Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in Heart failure.
- The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic Heart failure.
- Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic Heart failure.
- Functional genomics applied to cardiovascular medicine.
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intraCoronary gene therapy of sarcoplasmic reticulum...
- Impact of worsening renal function during the treatment of decompensated Heart failure on changes in renal function during subsequent hospitalization.
- Homeodomain only protein x is down-regulated in human Heart failure.
- Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual Heart failure risk variation.
- Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
- High-sensitivity ST2 for prediction of adverse outcomes in chronic Heart failure.
- Gene coexpression network topology of cardiac development, hypertrophy, and Failure.
- Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
- Association of an intronic, but not any exonic, FRMD4B sequence variant and Heart failure.
- Strong synaptic transmission impact by copy number variations in schizophrenia.
- Gene-expression profiling for rejection surveillance after cardiac transplantation.
- Klf15 deficiency is a molecular link between heart failure and aortic Aneurysm formation.
- Reciprocal regulation of metabolic and signaling pathways.
- Common variants in HSPB7 and FRMD4B associated with advanced Heart failure.
- Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with Heart failure.
- Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with Disease.
- Evidence for coregulation of myocardial gene expression by MEF2 and NFAT in human Heart failure.
- Sex and age dimorphism of myocardial gene expression in nonischemic human Heart failure.
- N-terminal pro-brain natriuretic Peptide as a biomarker for Hypertensive disorders of pregnancy.
- Clinical and genetic modifiers of long-term survival in Heart failure.
- Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic Heart failure.
- Gene profiling of human adipose tissue during evoked inflammation in vivo.
- Calcium upregulation by percutaneous administration of gene therapy in cardiac Disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.
- Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.
- Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or Coronary atherosclerosis in nondiabetic Caucasi...
- Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic Heart failure.
- Molecular remodeling in human Heart failure.
- GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo.
- Transcriptional genomics associates FOX transcription factors with human Heart failure.
- Predictors of remodeling in the CRT era: influence of Mitral regurgitation, BNP, and gender.
- GATA-6 regulates genes promoting synthetic functions in vascular smooth muscle cells.
- Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
- Endomyocardial biopsy plays a role in diagnosing patients with unexplained Cardiomyopathy.
- Mortality in primary and secondary myocarditis.
- Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice.
- Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy.
- Pulmonary hypertension and risk of death in Cardiomyopathy: patients with myocarditis are at higher risk.
- Nitric oxide regulates the Heart by spatial confinement of nitric oxide synthase isoforms.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Johns Hopkins Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Brigham and Women's Hospital -
Harvard Medical School
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1437185584 | |
| NPPES Provider LastName | CAPPOLA | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 169.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437185584 |
| Last Name Of The Provider | CAPPOLA |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Michael A. Valentino, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Ramesh K. Adiraju, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hayan Al Maluli, MD |
|
|
Dr. Marc A. Tecce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aman M. Amanullah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Keisman, MD |
|
|
Dr. Scott L. Midwall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shadi Idris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria M. Mountis, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin A. O'Malley Tysko, MD
This Doctor is OpenDoctor Recommended.
|